RESULTS	In the overall population primary endpoint occurred in 6.7 % of patients in the reload vs. 8.8 % in the placebo arm [ odds ratios ( OR ) 0.75 , 95 % confidence intervals ( CI ) 0.37-1 .52 ; P = 0.50 ] .\